dc.contributor.author | Radzevičiūtė, Eivina | |
dc.contributor.author | Malyško-Ptašinskė, Veronika | |
dc.contributor.author | Kulbacka, Julita | |
dc.contributor.author | Rembiałkowska, Nina | |
dc.contributor.author | Novickij, Jurij | |
dc.contributor.author | Girkontaitė, Irutė | |
dc.contributor.author | Novickij, Vitalij | |
dc.date.accessioned | 2023-09-18T16:21:11Z | |
dc.date.available | 2023-09-18T16:21:11Z | |
dc.date.issued | 2022 | |
dc.identifier.issn | 1567-5394 | |
dc.identifier.other | (crossref_id)140196157 | |
dc.identifier.uri | https://etalpykla.vilniustech.lt/handle/123456789/113404 | |
dc.description.abstract | Electroporation is a pulsed electric field (PEF) induced phenomenon, which effectiveness varies dependent on pulse parameters. This work focuses on nano-electrochemotherapy with bleomycin and doxorubicin to derive protocols as effective as European Standard Operating Procedures on Electrochemotherapy (ESOPE), which employ conventional microsecond range pulses. As a model, murine Lewis lung carcinoma (LLC1) cell line was used. The effects of pulse duration (100–500 ns), PEF amplitude (6–10 kV/cm) and pulse repetition frequency (10 kHz, 100 kHz, 1 MHz) were studied. A total of 75 ns protocol variations have been used. For detection of cell permeabilization, Yo-Pro-1 and flow cytometry were employed. Cell viability was evaluated 24-, 48-, or 72-hours post-electroporation. Nanosecond parametric protocols resulting in comparable treatment efficiency as ESOPE (1.3 kV/cm × 100 μs × 8) have been proposed. It was shown that high-frequency nanosecond electrochemotherapy with bleomycin or doxorubicin could be an alternative for established ESOPE protocols. | eng |
dc.format | PDF | |
dc.format.extent | p. 1-12 | |
dc.format.medium | tekstas / txt | |
dc.language.iso | eng | |
dc.relation.isreferencedby | Science Citation Index Expanded (Web of Science) | |
dc.relation.isreferencedby | Scopus | |
dc.rights | Laisvai prieinamas internete | |
dc.source.uri | https://talpykla.elaba.lt/elaba-fedora/objects/elaba:139237487/datastreams/MAIN/content | |
dc.title | Nanosecond electrochemotherapy using bleomycin or doxorubicin: Influence of pulse amplitude, duration and burst frequency | |
dc.type | Straipsnis Web of Science DB / Article in Web of Science DB | |
dcterms.references | 59 | |
dc.type.pubtype | S1 - Straipsnis Web of Science DB / Web of Science DB article | |
dc.contributor.institution | Valstybinis mokslinių tyrimų institutas Inovatyvios medicinos centras | |
dc.contributor.institution | Vilniaus Gedimino technikos universitetas | |
dc.contributor.institution | Wroclaw Medical University | |
dc.contributor.faculty | Elektronikos fakultetas / Faculty of Electronics | |
dc.subject.researchfield | T 001 - Elektros ir elektronikos inžinerija / Electrical and electronic engineering | |
dc.subject.researchfield | N 010 - Biologija / Biology | |
dc.subject.vgtuprioritizedfields | MC0505 - Inovatyvios elektroninės sistemos / Innovative Electronic Systems | |
dc.subject.ltspecializations | L105 - Sveikatos technologijos ir biotechnologijos / Health technologies and biotechnologies | |
dc.subject.en | ESOPE | |
dc.subject.en | nanosecond electroporation | |
dc.subject.en | membrane permeabilization | |
dc.subject.en | cancer | |
dc.subject.en | drugs | |
dc.subject.en | NsPEF | |
dc.subject.en | high frequency | |
dcterms.sourcetitle | Bioelectrochemistry | |
dc.description.volume | vol. 148 | |
dc.publisher.name | Elsevier | |
dc.publisher.city | Lausanne | |
dc.identifier.doi | 140196157 | |
dc.identifier.doi | 000863189300005 | |
dc.identifier.doi | 10.1016/j.bioelechem.2022.108251 | |
dc.identifier.elaba | 139237487 | |